| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/19/2001 | WO2001027159A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 04/19/2001 | WO2001027151A1 A new polypeptide-human zinc finger protein kruppel family member zfp-52 and the polynucleotide encoding it |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027146A2 Chemokine receptor |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027129A1 Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof |
| 04/19/2001 | WO2001027127A1 Tamoxifen and tamoxifen analogue glycosides and uses thereof |
| 04/19/2001 | WO2001027116A2 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 04/19/2001 | WO2001027115A1 Pentacyclic taxane compounds |
| 04/19/2001 | WO2001027114A1 PYRROLO[2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS |
| 04/19/2001 | WO2001027113A2 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES |
| 04/19/2001 | WO2001027106A1 Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| 04/19/2001 | WO2001027102A1 Substituted diazepanes |
| 04/19/2001 | WO2001027101A2 Anhydrous salt |
| 04/19/2001 | WO2001027090A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRINαvβ3 ANTAGONISM |
| 04/19/2001 | WO2001027089A1 Pyrimidine derivatives |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027082A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN αvβ3 ANTAGONISTS |
| 04/19/2001 | WO2001027081A1 6-position substituted indoline, production and use thereof as a medicament |
| 04/19/2001 | WO2001027079A2 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | WO2001026693A2 Manufacture of polyglutamate-therapeutic agent conjugates |
| 04/19/2001 | WO2001026683A2 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 04/19/2001 | WO2001026682A2 Modified plant viruses and methods of use thereof |
| 04/19/2001 | WO2001026680A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | WO2001026677A1 Interferon complex and medicinal use thereof |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2001026672A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | WO2001026669A1 A nascent gold based herbal composition |
| 04/19/2001 | WO2001026668A1 Compositions with anti-prostate cancer activity |
| 04/19/2001 | WO2001026661A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026645A1 Method for protecting normal cells from cytotoxicity of chemotherapeutic agents |
| 04/19/2001 | WO2001026644A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/19/2001 | WO2001026629A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026628A1 Cationic dosper virosomes |
| 04/19/2001 | WO2001026627A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | WO2001026625A2 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | WO2001026467A1 Methods of enhancing chemotherapy |
| 04/19/2001 | WO2001019846A8 Transgenically produced fusion proteins |
| 04/19/2001 | WO2001014557B1 Pd-1, a receptor for b7-4, and uses therefor |
| 04/19/2001 | WO2000075158A3 NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS |
| 04/19/2001 | WO2000071078A3 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000067762A3 Selenium-containing pro-drugs for cancer therapy |
| 04/19/2001 | WO2000065073A3 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same |
| 04/19/2001 | WO2000057867A3 Improved cancer treatment with temozolomide |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | WO1999032448A8 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 04/19/2001 | WO1998008546A8 Therapeutic combinations of rar antagonists and rxr agonists and use thereof |
| 04/19/2001 | US20010000344 N-(2-(R)-amino-3-mercaptopropyl)-L-penicillaminyl-1,2,3,4 -tetrahydro-3(S)-isoquinoline carbonyl methionine methylester cyclic disulfide, for example; administering as antitumor agent or to treat restenosis |
| 04/19/2001 | DE19949208A1 New 3-(amino-methylene)-2-indolinone derivatives are kinase inhibitors and cell proliferation inhibitors useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
| 04/19/2001 | DE19948417A1 Imidazol-Derivate und ihre Verwendung als Arzneimittel Imidazole derivatives and their use as medicaments |
| 04/19/2001 | DE19947668A1 Tumorspezifischer Vektor für die Gentherapie A tumor-specific vector for gene therapy |
| 04/19/2001 | DE19947297A1 Cyclische Biphenyle, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel Cyclic biphenyls, processes for their preparation and their use as medicaments |
| 04/19/2001 | DE19946301A1 Antitumor agents and angiogenesis inhibitors having low neurotoxicity, comprise indole-3-glyoxylamide derivatives, are effective against resistant and metastasis-forming carcinomas |
| 04/19/2001 | DE10039844A1 New vector useful in the treatment of malignant disease and other hyperplasia |
| 04/19/2001 | CA2399093A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
| 04/19/2001 | CA2392209A1 M-substituted benzoic acid derivatives having integrin .alpha.v.beta.3 antagonistic activity |
| 04/19/2001 | CA2389652A1 Archaeosomes as immunomodulating carriers for acellular vaccines to induce cytotoxic t lymphocyte(ctl) responses and protect the vaccinated host against intracellular pathogens and cancer |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2388053A1 Cationic dosper virosomes |
| 04/19/2001 | CA2387629A1 Modified plant viruses and methods of use thereof |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2387205A1 Interferon complex and pharmaceutical use thereof |
| 04/19/2001 | CA2387184A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | CA2387145A1 Liposome encapsulated silver salt compositions |
| 04/19/2001 | CA2387063A1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | CA2386164A1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 04/19/2001 | CA2385792A1 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
| 04/19/2001 | CA2385196A1 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | CA2385186A1 Induction of a strong immune response to a self-tumor associated antigen |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2385071A1 Substituted pyrroles as antiproliferative agents for the treatment of cancer |
| 04/19/2001 | CA2382937A1 Anhydrous salt |
| 04/19/2001 | CA2382727A1 Methods of enhancing chemotherapy with the use of an imidazole |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/19/2001 | CA2381297A1 Pyrrolo¬2,3-d|pyrimidine nucleoside analogs |
| 04/18/2001 | EP1092779A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092765A2 Germination-activated red Ganoderma lucidum spores and method for producing the same |
| 04/18/2001 | EP1092719A2 Imidazo[5,1-f][1,2,4]triazine derivatives |
| 04/18/2001 | EP1092717A2 Polycyclic azaindole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092439A1 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 04/18/2001 | EP1092438A1 Pharmaceutical compositions containing growth-hormone inhibitors or their biologically active fragments for the treatment of uterine myomas |
| 04/18/2001 | EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/18/2001 | EP1092431A2 Lasofoxifene compositions |
| 04/18/2001 | EP1092028A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 04/18/2001 | EP1092026A2 Neurotransmission associated proteins |
| 04/18/2001 | EP1092023A2 Molecules associated with apoptosis |
| 04/18/2001 | EP1092013A1 3'-exonuclease, production and use thereof |